BioMarin Pharmaceutical Inc. (BMRN) earnings
BMRN earnings moved a median of -0.32% by the close. Quarterly and annual BMRN reports and results, each read against the price at its own news timestamp. Back to the BMRN overview →
28 measured BMRN earnings events.
Where these BMRN earnings landedvs 28 measured BMRN earnings reactions
| Middle 50% of BMRN earnings reactions | -1.20% to +1.06% |
|---|---|
| Median reaction (to close) | -0.32% |
| Measured reactions | 28 |
Point-in-time · zero look-ahead
Half of the 28 BMRN earnings events with a measured close landed between -1.20% and +1.06%; 43% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| BioMarin Reports Second Quarter 2026 Financial and Operating Results | Press release | -1.54% | -1.68% | |
| Form 10-Q BIOMARIN PHARMACEUTICAL For: Jun 30 | SEC filing · Form 10-Q | -1.54% | -1.68% | |
| BioMarin to Host Second Quarter 2026 Financial Results Conference Call and Webcast on Thursday, August 6, 2026, at 4:30pm ET | Press release | +0.31% | -0.03% | |
| Form 10-Q BIOMARIN PHARMACEUTICAL For: Mar 31 | SEC filing · Form 10-Q | -0.64% | -0.52% | |
| BioMarin Reports First Quarter 2026 Financial and Operating Results | Press release | +1.71% | -4.25% | |
| BioMarin to Host First Quarter 2026 Financial Results Conference Call and Webcast on Monday, May 4, 2026, at 4:30pm ET | Press release | -0.38% | +0.21% | |
| Form 10-K BIOMARIN PHARMACEUTICAL For: Dec 31 | SEC filing · Form 10-K | -0.18% | +1.13% | |
| Form 10-Q BIOMARIN PHARMACEUTICAL For: Sep 30 | SEC filing · Form 10-Q | -0.22% | -0.80% | |
| BioMarin Reports Third Quarter 2025 Results and Provides Corporate Update | Press release | +5.17% | +0.17% | |
| BioMarin to Host Third Quarter 2025 Financial Results Conference Call and Webcast on Monday, October 27, 2025, at 4:30pm ET | Press release | -0.04% | +2.21% | |
| Form 10-Q BIOMARIN PHARMACEUTICAL For: Jun 30 | SEC filing · Form 10-Q | -0.13% | -2.37% | |
| BioMarin Reports Strong Second Quarter 2025 Results and Raises Full-year Guidance¹ for Total Revenues, Non-GAAP Operating Margin, and Non-GAAP Diluted EPS | Press release | -4.33% | -0.91% | |
| BioMarin to Host Second Quarter 2025 Financial Results Conference Call and Webcast on Monday, August 4, 2025, at 4:30pm ET | Press release | +1.98% | +4.21% | |
| Form 10-Q BIOMARIN PHARMACEUTICAL For: Mar 31 | SEC filing · Form 10-Q | -0.10% | +1.16% | |
| BioMarin Reports First Quarter 2025 Results and Reaffirms Full-year Guidance | Press release | -1.26% | -4.45% | |
| BioMarin to Host First Quarter 2025 Financial Results Conference Call and Webcast on Thursday, May 1, 2025, at 4:30pm ET | Press release | -0.62% | +1.25% | |
| Form 10-K BIOMARIN PHARMACEUTICAL For: Dec 31 | SEC filing · Form 10-K | +0.23% | +0.10% | |
| Form 10-Q BIOMARIN PHARMACEUTICAL For: Sep 30 | SEC filing · Form 10-Q | +0.10% | -0.60% | |
| BioMarin to Host Third Quarter 2024 Financial Results Conference Call and Webcast on Tuesday, October 29, 2024, at 4:30pm ET | Press release | +0.18% | -0.11% | |
| Form 10-Q BIOMARIN PHARMACEUTICAL For: Jun 30 | SEC filing · Form 10-Q | -3.42% | -1.05% | |
| BioMarin to Host Second Quarter 2024 Financial Results Conference Call and Webcast on Monday, August 5, 2024, at 4:30pm ET | Press release | -0.13% | -1.00% | |
| Form 10-Q BIOMARIN PHARMACEUTICAL For: Mar 31 | SEC filing · Form 10-Q | -0.14% | -0.96% | |
| BioMarin Reports Record Financial Results for the First Quarter 2024 | Press release | -1.30% | -4.74% | |
| BioMarin to Host First Quarter 2024 Financial Results Conference Call and Webcast on Wednesday, April 24, 2024, at 4:30pm ET | Press release | +0.16% | +2.07% | |
| Form 10-K BIOMARIN PHARMACEUTICAL For: Dec 31 | SEC filing · Form 10-K | +0.36% | +1.03% | |
| Form 10-Q BIOMARIN PHARMACEUTICAL For: Sep 30 | SEC filing · Form 10-Q | -0.35% | +0.24% | |
| BioMarin Announces Strong Third Quarter 2023 Results, Including Continued Profitability, and 15% Total Revenue Growth Year Over Year | Press release | -1.27% | -1.64% | |
| BioMarin to Host Third-Quarter 2023 Financial Results Conference Call and Webcast on Wednesday, November 1, at 4:30pm ET | Press release | +0.38% | +2.65% |
Keep exploring
More BMRN: analyst actions → · SEC filings → · BMRN overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Hologic, Inc. (HOLX) | 357 | -0.00% | 44% |
| BioCardia, Inc. (BCDA) | 356 | -0.06% | 44% |
| McKesson Corporation (MCK) | 355 | +0.02% | 53% |
| Owens & Minor, Inc. (OMI) | 355 | -0.48% | 34% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.